CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 87 filers reported holding CYTOSORBENTS CORP in Q4 2018. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $163,000 | -23.8% | 32,359 | 0.0% | 0.01% | -27.3% |
| Q2 2019 | $214,000 | -74.4% | 32,359 | -70.7% | 0.01% | -76.6% |
| Q1 2019 | $837,000 | +75.8% | 110,530 | +87.8% | 0.05% | +34.3% |
| Q4 2018 | $476,000 | -37.4% | 58,851 | 0.0% | 0.04% | -20.5% |
| Q3 2018 | $760,000 | +13.3% | 58,851 | 0.0% | 0.04% | +2.3% |
| Q2 2018 | $671,000 | +61.7% | 58,851 | 0.0% | 0.04% | +53.6% |
| Q1 2018 | $415,000 | – | 58,851 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |